American Society Of Clinical Oncology

New Targets In Lung Cancer Shape Treatment Options

Thoracic oncologist Jack West talks about research presented at ASCO 2019 on new targets in lung cancer that may now be ready to move out of the research setting and into the clinic. Medscape Oncology
Related topics: Lung Cancer, Cancer, Oncology, Medical Research

Read More →

American Society For Radiation Oncology (astro) To Host Annual Meeting In Chicago, September 15-18

The American Society for Radiation Oncology (ASTRO) will host its 61st Annual Meeting at McCormick Place in Chicago, September 15-18, 2019. The meeting will feature updates on clinical trials, cancer research and new approaches that involve...
Related topics: American Cancer Society, Cancer, Oncology, Clinical Trials, Medical Research

Read More →

Healthcare Investor Brad Loncar Breaks Down Asco 2019's Winners And Losers

Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. The event is one of the most anticipated of the year for researchers...
Related topics: American Cancer Society, Cancer, Oncology, Medical Research

Read More →

Hashtag Medicine: Abstract Tweeted At Asco Ignites Debate

A tweet about how male and female presenters are introduced differently at ASCO meetings was divisive. Medscape Medical News
Related topics: Debate

Read More →

Asco Poster Rounds: Peptide Vaccine Yields Mixed Results In Prostate Ca

(MedPage Today) -- Also: novel BiTE immunotherapeutic shows promise; pembrolizumab combinations moving forward in mCRPC
Related topics: Vaccines

Read More →

More Practice-informing Data From Asco

(MedPage Today) -- News, features, and commentary about cancer-related issues
Related topics: Cancer, Oncology

Read More →

American Society Of Clinical Oncology, May 31-june 4

The 55th Annual Meeting of the American Society of Clinical Oncology The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 4 in Chicago and attracted approximately 20,000 participants from around the world,...
Related topics: Cancer, Oncology

Read More →

Was Asco Quieter For Big Drug/biotech Stocks This Year?

The world of cancer research is seeing huge developments and companies are taking great strides to find treatments for a variety of cancers.The five-day long ASCO conference, which is basically the most important annual cancer research event, held...
Related topics: Cancer, Oncology, Medical Research

Read More →

Asco: Enzalutamide Beneficial In Metastatic Prostate Cancer

WEDNESDAY, June 5, 2019 -- For men with metastatic, hormone-sensitive prostate cancer receiving testosterone suppression, enzalutamide is associated with significantly longer progression-free and overall survival, according to a study published...
Related topics: Prostate Cancer, Cancer, Oncology, Hormones, Medical Research

Read More →

Asco: Combo Regimen Effective In Cll With Coexisting Conditions

TUESDAY, June 4, 2019 -- Venetoclax-obinutuzumab is associated with longer progression-free survival than chlorambucil-obinutuzumab among patients with untreated chronic lymphocytic leukemia (CLL) and coexisting conditions, according to a study...
Related topics: Leukemia, Medical Research

Read More →

3 Drug Stocks That Could Win From Key Fda Approvals In June

Much of the biopharmaceutical world is abuzz right now thanks to the whirlwind of presentations at the American Society of Clinical Oncology (ASCO) meeting over the last few days. As always, some biotechs emerge as winners in the eyes of investors...
Related topics: Food And Drug Administration, Cancer, Oncology

Read More →

Here's Why Nektar Therapeutics Is Soaring Today

Shares of Nektar Therapeutics (NASDAQ: NKTR) rose more than 13% today after it announced an update for one of its most promising clinical programs at the 2019 American Society of Clinical Oncology (ASCO) meeting. A combination therapy comprising...
Related topics: Nasdaq, Cancer, Oncology

Read More →

Asco: Pembrolizumab Noninferior To Chemo In Advanced Gastric Cancer

MONDAY, June 3, 2019 -- Pembrolizumab is noninferior to chemotherapy for overall survival among patients with programmed death ligand 1, human epidermal growth factor receptor 2-negative, advanced gastric or gastroesophageal junction cancer,...
Related topics: Chemotherapy, Cancer, Oncology

Read More →

Why Genocea’s Neoantigen Treatment Is Such A Big Hit At Asco

Here is why Genocea Biosciences is one of the big winners from the annual meeting of the American Society of Clinical Oncology (ASCO).
Related topics: Cancer, Oncology

Read More →

2 Mayo Clinic Studies Examine Discrimination, Bias In Health Care Organizations

Two studies that explore types of discrimination and gender bias in health care organizations will be presented by Mayo Clinic researchers at the American Society of Clinical Oncology annual meeting in Chicago.
Related topics: Mayo Clinic, Medical Research, Cancer, Oncology

Read More →

'chemoboy' Takes Center Stage At Asco Meeting

Listening to what is important to the patient was a message highlighted at the opening ceremony of this year's annual meeting. Medscape Medical News

Read More →

Atlantic Health System Physicians Co-author Studies To Be Presented At American Society Of Clinical...

Studies to be presented at the ASCO meeting are co-authored by research oncologists Eric Whitman, MD; Missak Haigentz, MD; and Angela Alistar, MD. Their ASCO studies include: two separate studies looking at TILS therapy and Keytruda for advanced...
Related topics: Cancer, Oncology, Medical Research, Skin Cancer, Melanoma

Read More →

Hashtag Medicine: Tweeting At Asco

Use the main hashtag plus oncology 'micro-hashtags' to follow the conference on Twitter. Medscape Medical News
Related topics: Social Media, Cancer, Oncology

Read More →

Guidelines Updated For Radiotherapy After Prostatectomy

FRIDAY, May 31, 2019 -- Clinical guidelines on adjuvant and salvage radiotherapy after radical prostatectomy have been updated, according to the American Society for Radiation Oncology and the American Urological Association. Ian Murchie Thompson,...
Related topics: Cancer, Oncology

Read More →

Using Asco's Clinical Database For Commercial Research Raises Questions

Ethicists have expressed concern that a CancerLinQ database of deidentified patient medical records is being monetized for research without asking for informed consent. Medscape Medical News
Related topics: Medical Research

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.